Invesco Ltd. Lowers Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Invesco Ltd. lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 24.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 790,112 shares of the company's stock after selling 259,880 shares during the period. Invesco Ltd. owned 0.92% of Pediatrix Medical Group worth $10,366,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust raised its position in shares of Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares during the last quarter. AlphaQuest LLC raised its position in shares of Pediatrix Medical Group by 65.9% during the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after buying an additional 2,012 shares during the last quarter. Smartleaf Asset Management LLC raised its position in shares of Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock valued at $91,000 after buying an additional 6,090 shares during the last quarter. Finally, Bailard Inc. bought a new stake in Pediatrix Medical Group in the fourth quarter worth $161,000. Institutional investors own 97.71% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Truist Financial reduced their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $16.75.

Pediatrix Medical Group Trading Up 0.9 %

NYSE MD traded up $0.11 on Monday, hitting $12.36. 483,836 shares of the stock were exchanged, compared to its average volume of 840,193. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock has a fifty day moving average price of $14.01 and a two-hundred day moving average price of $13.99. The firm has a market capitalization of $1.06 billion, a P/E ratio of -10.30, a P/E/G ratio of 1.74 and a beta of 1.32. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.